pcn poster

Posters

Development of Deutetrabenazine as a Potential New Non-Antipsychotic Treatment for Tourette Syndrome in Children and Adolescents

Background: Tourette syndrome (TS) is a neurodevelopmental disorder characterized by the hyperkinetic movements of motor and phonic tics manifested in young age. Currently approved treatm...

Joseph Jankovic , MD;

Maria Wieman , MPH;

Barbara Coffey , MD, MS;

David Stamler , MD;

Daniel Claassen , MD;

Barry Gertz , MD, PhD;

Elisabeth Garofalo , MD;

Juha-Matti Savola , MD, PhD;

Mark Forrest Gordon , MD;

11/22/2019

Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in the Treatment of Children With Attention-Deficit/Hyperactivity Disorder

Objective: Determine if AMPH EROS has an onset of effect at 30 minutes post-dose in children with ADHD.

Antonio Pardo , MD;

Barry Herman , MD, MMM;

Ann Childress , MD;

Thomas King , MS, MPH;

11/22/2019

Association Between Depression Status and Dental Visits: Results From Korean National Health and Nutrition Examination Survey

Background: Literature showed that depression was strongly associated with poor oral health including dental caries and periodontitis. The aim of this study was to examine the association...

Euni Lee ;

11/22/2019

Treatment Experiences of Individuals With Schizophrenia: Findings From an Online Survey

Background: This study examined experiences of patients living with schizophrenia with a history of oral antipsychotic medication (OAM) use.

Julia Carpenter-Conlin , MSW;

Leona Bessonova , PhD;

Jakob Bjorner , MD, PhD;

Dawn Velligan , PhD;

Michael Doane , PhD;

Martha Sajatovic , MD;

Stephen Maher , PhD;

Asia Sikora Kessler , PhD;

11/22/2019

Descriptive Patterns Emerging From Initial Antidepressant Treatment Episodes in Patients with Treatment-Resistant Depression

Background: TRD leads to excess healthcare costs and burden of illness. Early patterns of antidepressant use may signify patients at high-risk for TRD. Methods: Eligible patients with ma...

John Verbanac , PhD;

Wing Chow , PharmD, MPH;

Jacqueline Pesa , PhD, MPH;

Charles Ruetsch , PhD;

Joshua Liberman , PhD;

Tigwa Davis , PhD;

Sara Heverly-Fitt , PhD;

11/22/2019

Post Marketing Rate of Seizures During Transcranial Magnetic Stimulation (TMS) Treatment With NeuroStar® Advanced Therapy Appears to Be Lower Than Previously Estimated

Transcranial magnetic stimulation (TMS) delivered with the NeuroStar® Advanced Therapy System is an effective acute treatment for patients with major depressive disorder (MDD). With TMS, ...

Karen Heart , BS, MBA;

Philip Janicak , MD;

Bridget McGugan , PharmD, MBA;

11/22/2019

National Trends in the Prevalence of Major Depressive Disorder With Suicidal Ideation Among Adults Using National Survey on Drug Use and Health Data

Introduction: Although depression is a known risk factor for suicide, little is known about how the prevalence of co-occurring major depressive disorder (MDD) and suicidal ideation/behavi...

Ella Daly , MB, BCh, BAO;

Kun Wang , PhD;

Harsh Kuvadia ;

John J. Sheehan , PhD, MBA, RPh;

Jennifer Voelker , MS, PharmD;

Jacqueline Pesa , PhD, MPH;

Nancy Connolly , MPH;

Ayush Srivastava , BS ;

11/22/2019

The Efficacy of Lumateperone 42 mg in the Treatment of Schizophrenia: A Pooled Analysis of Randomized Controlled Trials

Introduction: Lumateperone (lumateperone tosylate, ITI-007) is in late-phase clinical development for schizophrenia. Lumateperone has a unique mechanism of action that simultaneously modu...

Robert Davis , PhD;

Kimberly Vanover , PhD;

Andrew Satlin , MD;

Carol Tamminga , MD;

Sharon Mates , PhD;

Tobie Escher , PhD;

11/22/2019

Combinatorial Pharmacogenomic Testing Improves Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized, Controlled Trial

Objectives: The GUIDED trial demonstrated that combinatorial pharmacogenomic (PGx) testing significantly improved the rate of response (p=0.007) and remission (p=0.005) and approached sig...

John Greden , MD;

Anthony Rothschild , MD;

Michael Thase , MD;

Boadie Dunlop , MD;

Richard Shelton , MD;

Charles Conway , MD;

Lisa Brown , PhD;

Jennie Depatie , PhD;

Brent Forester , MD, MSc;

James Li , MS, PhD;

Matthew Macaluso , DO;

Krystal Brown , PhD;

Michael J. Crescenz ;

Michael Jablonski , PhD;

Charles DeBattista , MD;

Sagar Parikh , MD;

11/22/2019

Dasotraline for Treatment of Adults With Binge-Eating Disorder: Effect on Binge-related Obsessions and Compulsions

Background: In a previous study, dasotraline, a long-acting dopamine/norepinephrine reuptake inhibitor, demonstrated efficacy in the treatment of binge-eating disorder (BED). We now repor...

Leslie Citrome , MD;

Robert Goldman , PhD;

Ling Deng , PhD;

Todd Grinnell , BA;

Andrei Pikalov , MD, PhD;

Joyce Tsai , PhD;

11/22/2019

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Posters

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products